REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 58 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Lessors of Other Real Estate Property | Advertising Agencies | Office Administrative Services
Full name: Dr.Max 58 S.R.O. Profile Updated: July 30, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Dr.Max 58 S.R.O. is an enterprise in Slovakia, with the main office in Kosice. The company operates in the Pharmacies and Drug Stores sector. The company was established on March 21, 2014. It currently has a total number of 5 - 9 (2025) employees. In 2024, the company reported a net sales revenue increase of 5.93%. There was a total negative growth of 0.17% in Dr.Max 58 S.R.O.’s total assets over the same period. The net profit margin of Dr.Max 58 S.R.O. decreased by 0.19% in 2024.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 58 S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Dr.Max 58 S.R.O. report to view the information.
Registered Capital:
Purchase the Dr.Max 58 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 58 S.R.O. report to view the information.
Incorporation Date:
March 21, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 58 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
5.93%
Total operating revenue
5.84%
Operating profit (EBIT)
-4.2%
EBITDA
0.2%
Net Profit (Loss) for the Period
-6.34%
Total Assets
-0.17%
Total Equity
14.53%
Operating Profit Margin (ROS)
-0.2%
Net Profit Margin
-0.19%
Return on Equity (ROE)
-2.82%
Debt/Equity
-0.55%
Quick Ratio
0.02%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?